AI-based Clinical Trials Solution Provider Market Size, Statistics
The global AI-based clinical trials solution provider market size was worth around USD 2.13 billion in 2024 and is predicted to grow to around USD 19.03 billion by 2035 with a compound annual growth rate (CAGR) of 22.03% from 2025 to 2035. The market growth is boosted by AI-driven platforms that are revolutionizing drug development by enhancing efficiency, reducing delays, and enabling decentralized trial models. Continued investment and collaboration are set to sustain long-term growth and innovation in the clinical trial landscape.